| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of FGF13 protein | affects expression | 20106945
|
| D005680 |
gamma-Aminobutyric Acid |
FGF13 protein results in increased uptake of gamma-Aminobutyric Acid | increases uptake | 9751161
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of FGF13 mRNA | decreases expression | 20106945 20064835
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of FGF13 mRNA | increases expression | 20127859
|
| C053541 |
bicalutamide |
bicalutamide results in increased expression of FGF13 mRNA | increases expression | 15638997
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of FGF13 mRNA | increases expression | 20106945
|
| D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of FGF13 mRNA | affects cotreatment|increases expression | 19619570
|
| D004958 |
Estradiol |
Estradiol results in increased expression of FGF13 mRNA | increases expression | 19619570
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of FGF13 mRNA | increases expression | 17557909
|
| C533894 |
LG 100815 |
LG 100815 results in increased expression of FGF13 mRNA | increases expression | 16951191
|
| C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of FGF13 mRNA | increases expression | 17616710
|
| C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in increased expression of FGF13 mRNA | increases expression | 16951191
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FGF13 mRNA | affects binding|decreases expression|increases activity | 19710929
|
| D012964 |
Sodium |
FGF13 protein promotes the reaction [SCN8A protein affects the transport of Sodium] | affects transport|increases reaction | 15282281
|
| D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of FGF13 mRNA | affects cotreatment|increases expression | 19619570
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FGF13 mRNA | increases expression | 19619570
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 14514962 15322242 11752688 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.12 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.12 | 11473722 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.12 | 14692618 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.70 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.30 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.30 | 16835633 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.18 | 19183758 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.57 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.71 | 15885639 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.04 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.04 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.79 | 17474063 20146248 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.79 | 17261762 12948864 19861407 17289903 14630087 16675129 18497071 17018787 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.79 | 20435547 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.58 | 16111702 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.07 | 12619106 21507988 12907637 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.07 | 16924424 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.07 | 20419170 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.76 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.76 | 18566989 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.70 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.70 | 16919318 17110522 16105132 17333356 17681005 11677210 15861022 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.70 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 15668235 8697196 12621046 15340226 16354765 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.48 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.55 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
6.81 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.81 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 18230668 15322242 16714409 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.28 | 12538720 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.03 | 11473722 19148513 18566989 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 9294722 10568697 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.67 | 16530937 |
| MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
4.67 | 16510608 15623463 15547733 16704527 15264214 15150132 16805852 15547721 15878914 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.48 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.48 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.48 | 19236843 20131406 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12639820 12168785 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.83 | 20067830 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.58 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.58 | 10048152 11294989 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.58 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.61 | 19176532 18467677 19772884 16221962 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.61 | 12621046 15340226 16120746 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.17 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.89 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 15340226 16959395 8697196 18606429 16354765 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.04 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.04 | 18670907 18850075 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16945680 16569931 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.54 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.89 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.37 | 16627594 16393666 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.37 | 16306350 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.08 | 8314463 10903974 18776723 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.08 | 15618244 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.50 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.50 | 15610895 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.42 | 14659978 14716833 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.42 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.42 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
10.91 | 9163691 15890375 2125692 18177683 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.91 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.91 | 20007298 16377806 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.91 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.97 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.97 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.41 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.41 | 18569708 20869020 20464547 20064080 20135361 17053015 18816296 18520028 6695378 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.41 | 11884234 19555203 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.61 | 11807958 16891317 11408345 17203775 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.62 | 19453300 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.25 | 16381670 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.17 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.46 | 16810080 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.46 | 16411023 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.95 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.95 | 17405874 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.85 | 17289903 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 18481113 19348381 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.78 | 16427766 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.78 | 14600291 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.83 | 20558911 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.24 | 19401270 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.31 | 11896295 11118676 11399792 11222880 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.97 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.64 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
2.64 | 17914592 19240160 19011039 18487222 15638997 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.64 | 16740699 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 15861022 16919318 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.42 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.59 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.59 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.08 | 16709447 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.56 | 2093021 20155912 |
| MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.56 | 17575124 12958204 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.82 | 19048282 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.20 | 17053015 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.39 | 14692618 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |